RNA, U6 small nuclear 411, pseudogene (RNU6-411P)

RNU6-411P (RNA, U6 small nuclear 411, pseudogene) is a pseudogene related to U6 small nuclear RNA (snRNA), annotated in the human genome as a non-coding RNA locus[2]. Unlike canonical, functional U6 snRNA, which is essential for pre-mRNA splicing as part of the spliceosome[3][5], RNU6-411P represents an inactive, non-functional genomic copy of the U6 snRNA gene that arose by retrotransposition or other mechanisms and does not produce a functional RNA product[2][1]. Pseudogenes such as RNU6-411P are not translated into protein, generally lack regulatory function, and are not direct therapeutic targets[4][2]. Some pseudogenes can generate RNA transcripts with regulatory roles (such as antisense RNAs, competing endogenous RNAs, or serving as decoys for microRNAs)[4], but there is currently no evidence in the literature for such a function by RNU6-411P specifically. The core gene family—the U6 snRNA genes—are highly conserved and critical for splicing catalysis, but this pseudogene is not functionally involved in splicing or known disease mechanisms[2][5]. No drugs, mechanism of action, validated biomarker role, or therapeutic safety concerns are associated with RNU6-411P. Because RNU6-411P does not encode a functional protein or RNA, and is not a drug target or known biomarker, it is not considered a therapeutic target and should not be included in pharmacological or therapeutic target lists[2][5]. Its presence in the genome reflects the high evolutionary conservation and redundancy of essential RNA genes like U6 snRNA[5].

Other names

RNU6-411P